Mid Continent Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Mid Continent Capital’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.42M	Sell	21,355 -130	-0.6%	-$10.1K	0.09%	131
2015 Q2	$1.68M	Sell	21,485 -475	-2%	-$37K	0.09%	143
2015 Q1	$1.68M	Sell	21,960 -425	-2%	-$31.2K	0.09%	146
2014 Q4	$1.49M	Sell	22,385 -935	-4%	-$62.3K	0.08%	149
2014 Q3	$1.48M	Sell	23,320 -290	-1%	-$17.9K	0.09%	153
2014 Q2	$1.44M	Sell	23,610 -3,490	-13%	-$202K	0.08%	158
2014 Q1	$1.53M	Sell	27,100 -50	-0.2%	-$2.84K	0.09%	150
2013 Q4	$1.45M	Buy	27,150 +850	+3%	+$42.5K	0.09%	148
2013 Q3	$1.21M	Buy	26,300 +3,350	+15%	+$153K	0.09%	159
2013 Q2	$970K	Buy	+22,950	New	+$955K	0.07%	162

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Mid Continent Capital's PJP Position: Q3 2015 in Review

Mid Continent Capital reduced its Invesco Pharmaceuticals ETF (PJP) stake by 0.61% in Q3 2015, selling an estimated $10.1K and leaving 21,355 shares worth $1.42M. The position accounts for 0.09% of the portfolio, ranked #131.

Mid Continent Capital first reported a position in PJP in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.68M in Q2 2015. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

Mid Continent Capital held 21,355 shares of Invesco Pharmaceuticals ETF worth $1.42M as of Q3 2015.
Mid Continent Capital sold 130 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $10.1K.
Invesco Pharmaceuticals ETF made up 0.09% of Mid Continent Capital's portfolio in Q3 2015, its #131 holding.
Mid Continent Capital first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Invesco Pharmaceuticals ETF position peaked at $1.68M in Q2 2015.
106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.